You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,952,968


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,952,968 protect, and when does it expire?

Patent 10,952,968 protects SYMPROIC and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 10,952,968
Patent landscape, scope, and claims:
Title:Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
Abstract: The solid preparation which improved the dissolution profile and the stability of the 6,7-unsaturation-7-carbamoyl morphinan derivative is provided. When 6,7-unsaturation-7-carbamoyl morphinan derivative, croscarmellose sodium and ferric oxide were contained, not titanium oxide in the solid preparations and the coating solid preparations, a dissolution rate after 15 minutes of the dissolution test is more than 85%, and stability, particularly, light stability can be improve.
Inventor(s): Mashimo; Akira (Osaka, JP), Ichio; Shunji (Osaka, JP), Tamura; Yoshinori (Osaka, JP), Noguchi; Kouichi (Hyogo, JP)
Assignee: SHIONOGI & CO., LTD. (Osaka, JP)
Application Number:14/401,388
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Dosage form;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,952,968

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bdsi SYMPROIC naldemedine tosylate TABLET;ORAL 208854-001 Mar 23, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,952,968

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
JapanJP2012-110417May 14, 2012
PCT Information
PCT FiledMay 13, 2013PCT Application Number:PCT/JP2013/063278
PCT Publication Date:November 21, 2013PCT Publication Number: WO2013/172297

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.